Search research articles
Contact Us
Filters
Showing results (61-70 of 255) with videos related to
Page
of 26
Sort By:
International Journal of Oncology
|
June 15, 2006
Expression analysis of genes involved in oxaliplatin response and development of oxaliplatin-resistant HT29 colon cancer cells
C Plasencia, E Martínez-Balibrea, A Martinez-Cardús, et al.
American Journal of Clinical Oncology
|
May 14, 2020
Eligibility Criteria and Endpoints in Metastatic Renal Cell Carcinoma Trials
Sarah E Wong, David I Quinn, Georg A Bjarnason, et al.
Theranostics
|
March 21, 2020
Comparative prognostic implication of treatment response assessments in mCRPC: PERCIST 1.0, RECIST 1.1, and PSA response criteria
Erik M Velez, Bhushan Desai, Lingyun Ji, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
March 31, 2019
Prediction of Time to Hormonal Treatment Failure in Metastatic Castration-Sensitive Prostate Cancer with <sup>18</sup>F-FDG PET/CT
Hossein Jadvar, Erik M Velez, Bhushan Desai, et al.
BJU International
|
March 30, 2005
Molecular prognostic factors in bladder cancer
Maurizio Buscarini, Marcus L Quek, Parkash Gill, et al.
Molecular Cancer Therapeutics
|
February 22, 2012
Novel therapies for metastatic renal cell carcinoma: efforts to expand beyond the VEGF/mTOR signaling paradigm
Sumanta Kumar Pal, Stephen Williams, David Y Josephson, et al.
Molecular Cancer Therapeutics
|
July 16, 2005
Discovery and preclinical evaluation of a novel class of small-molecule compounds in hormone-dependent and -independent cancer cell lines
Carmen Plasencia, Raveendra Dayam, Qingcai Wang, et al.
Psychiatric Services (Washington, D.C.)
|
February 3, 2011
One-year follow-up of collaborative depression care for low-income, predominantly Hispanic patients with cancer
Kathleen Ell, Bin Xie, Suad Kapetanovic, et al.
General Hospital Psychiatry
|
May 9, 2007
Improving treatment of depression among low-income patients with cancer: the design of the ADAPt-C study
Kathleen Ell, Brenda Quon, David I Quinn, et al.
Expert Review of Anticancer Therapy
|
October 14, 2005
Postchemotherapy residual masses in advanced seminoma: current management and outcomes
Marcus L Quek, Vannita Simma-Chiang, John P Stein, et al.
Page
of 26
Search research articles
Search
Showing results (61-70 of 255) with videos related to
Sort By:
Page
of 26
International Journal of Oncology
|
June 15, 2006
Expression analysis of genes involved in oxaliplatin response and development of oxaliplatin-resistant HT29 colon cancer cells
C Plasencia, E Martínez-Balibrea, A Martinez-Cardús, et al.
American Journal of Clinical Oncology
|
May 14, 2020
Eligibility Criteria and Endpoints in Metastatic Renal Cell Carcinoma Trials
Sarah E Wong, David I Quinn, Georg A Bjarnason, et al.
Theranostics
|
March 21, 2020
Comparative prognostic implication of treatment response assessments in mCRPC: PERCIST 1.0, RECIST 1.1, and PSA response criteria
Erik M Velez, Bhushan Desai, Lingyun Ji, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
March 31, 2019
Prediction of Time to Hormonal Treatment Failure in Metastatic Castration-Sensitive Prostate Cancer with <sup>18</sup>F-FDG PET/CT
Hossein Jadvar, Erik M Velez, Bhushan Desai, et al.
BJU International
|
March 30, 2005
Molecular prognostic factors in bladder cancer
Maurizio Buscarini, Marcus L Quek, Parkash Gill, et al.
Molecular Cancer Therapeutics
|
February 22, 2012
Novel therapies for metastatic renal cell carcinoma: efforts to expand beyond the VEGF/mTOR signaling paradigm
Sumanta Kumar Pal, Stephen Williams, David Y Josephson, et al.
Molecular Cancer Therapeutics
|
July 16, 2005
Discovery and preclinical evaluation of a novel class of small-molecule compounds in hormone-dependent and -independent cancer cell lines
Carmen Plasencia, Raveendra Dayam, Qingcai Wang, et al.
Psychiatric Services (Washington, D.C.)
|
February 3, 2011
One-year follow-up of collaborative depression care for low-income, predominantly Hispanic patients with cancer
Kathleen Ell, Bin Xie, Suad Kapetanovic, et al.
General Hospital Psychiatry
|
May 9, 2007
Improving treatment of depression among low-income patients with cancer: the design of the ADAPt-C study
Kathleen Ell, Brenda Quon, David I Quinn, et al.
Expert Review of Anticancer Therapy
|
October 14, 2005
Postchemotherapy residual masses in advanced seminoma: current management and outcomes
Marcus L Quek, Vannita Simma-Chiang, John P Stein, et al.
Page
of 26